Sanofi India Limited has informed the Exchange about Resignation of Senior Management Personnel of the Company
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Suresh Babu, Sales & Customer Engagement Head – Diabetes, has resigned from Sanofi India effective close of business on 12th February 2026. He is leaving to pursue opportunities outside the Sanofi group. His resignation email was sent on 4th February 2026, and his exit was completed the same day with handover finished. The disclosure has been made to BSE and NSE under SEBI Listing Regulations, with his resignation letter attached as Annexure I.
This is a functional-level senior management exit in the diabetes division, not a CEO, CFO or Managing Director change. Limited direct impact on stock price is expected, though investors may watch for any further senior departures or succession announcements from the company.